These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36455903)

  • 1. A Narrative Review of the Pathophysiology and Treatment of Hypertrophic Cardiomyopathy.
    Gelpi Acevedo LM; Salinas AL; Polanco JS; Nizami H; Marsh D; Patel M; Parikh K; Jain R; Jain R
    South Med J; 2022 Dec; 115(12):926-929. PubMed ID: 36455903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and emerging perspectives on pathophysiology, diagnosis, and management of hypertrophic cardiomyopathy.
    Gartzonikas IK; Naka KK; Anastasakis A
    Hellenic J Cardiol; 2023; 70():65-74. PubMed ID: 36403865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Genetic Basis of Hypertrophic Cardiomyopathy.
    Marian AJ
    Circ Res; 2021 May; 128(10):1533-1553. PubMed ID: 33983830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple algorithm for a clinical step-by-step approach in the management of hypertrophic cardiomyopathy.
    Efthimiadis G; Zegkos T; Parcharidou D; Ntelios D; Panagiotidis T; Gossios T; Karvounis H
    Future Cardiol; 2021 Nov; 17(8):1395-1405. PubMed ID: 33615852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy.
    Subasic K
    Nurs Clin North Am; 2013 Dec; 48(4):571-84. PubMed ID: 24295188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy: evaluation and treatment of patients at high risk for sudden death.
    Fananapazir L; McAreavey D
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 2):478-501. PubMed ID: 9058851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique Aspects of Hypertrophic Cardiomyopathy in Children.
    Townsend M; Jeewa A; Khoury M; Cunningham C; George K; Conway J
    Can J Cardiol; 2024 May; 40(5):907-920. PubMed ID: 38244986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.
    Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R
    J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic Cardiomyopathy: An Overview of Genetics and Management.
    Teekakirikul P; Zhu W; Huang HC; Fung E
    Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31888115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.
    Kuusisto J; Sipola P; Jääskeläinen P; Naukkarinen A
    Ann Med; 2016 Nov; 48(7):496-508. PubMed ID: 27460395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy: genetics and clinical perspectives.
    Wolf CM
    Cardiovasc Diagn Ther; 2019 Oct; 9(Suppl 2):S388-S415. PubMed ID: 31737545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical Treatment Strategies for Hypertrophic Cardiomyopathy.
    Hutt E; Desai MY
    Am J Cardiol; 2024 Feb; 212S():S33-S41. PubMed ID: 38368034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation-specific pathology and treatment of hypertrophic cardiomyopathy in patients, mouse models and human engineered heart tissue.
    Wijnker PJM; van der Velden J
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165774. PubMed ID: 32217077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular genetic basis for hypertrophic cardiomyopathy.
    Marian AJ; Roberts R
    J Mol Cell Cardiol; 2001 Apr; 33(4):655-70. PubMed ID: 11273720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia.
    Wolf CM; Moskowitz IP; Arno S; Branco DM; Semsarian C; Bernstein SA; Peterson M; Maida M; Morley GE; Fishman G; Berul CI; Seidman CE; Seidman JG
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18123-8. PubMed ID: 16332958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy: diagnosis and therapeutic options.
    Gluckman TJ
    Am J Manag Care; 2021 Apr; 27(6 Suppl):S111-S117. PubMed ID: 33861535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathology of hypertrophic cardiomyopathy.
    Hughes SE
    Histopathology; 2004 May; 44(5):412-27. PubMed ID: 15139989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury.
    Marian AJ; Roberts R
    Ann Med; 1998 Aug; 30 Suppl 1():24-32. PubMed ID: 9800880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical therapies for hypertrophic cardiomyopathy: Current state of the art.
    Desai MY; Owens A; Wang A
    Prog Cardiovasc Dis; 2023; 80():32-37. PubMed ID: 37619712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.